Vimab Group AB (publ) (STO: VIMAB)
Sweden
· Delayed Price · Currency is SEK
10.90
-0.40 (-3.54%)
At close: Jan 28, 2025
Vimab Group AB Revenue
Vimab Group AB had revenue of 75.97M SEK in the quarter ending September 30, 2024, a decrease of -23.35%. This brings the company's revenue in the last twelve months to 353.19M, up 19.84% year-over-year. In the year 2023, Vimab Group AB had annual revenue of 342.35M with 50.62% growth.
Revenue (ttm)
353.19M
Revenue Growth
+19.84%
P/S Ratio
0.69
Revenue / Employee
1.50M
Employees
170
Market Cap
255.78M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 342.35M | 115.06M | 50.62% |
Dec 31, 2022 | 227.29M | 21.61M | 10.51% |
Dec 31, 2021 | 205.68M | -11.17M | -5.15% |
Dec 31, 2020 | 216.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition